Endotypes of severe allergic asthma patients who clinically benefit from anti-IgE therapy.

Huang, Yu-Chen; Weng, Chih-Ming; Lee, Meng-Jung; Lin, Shu-Min; Wang, Chun-Hua; Kuo, Han-Pin

Huang, Yu-Chen; Weng, Chih-Ming; Lee, Meng-Jung; Lin, Shu-Min; Wang, Chun-Hua; Kuo, Han-Pin.

Afiliação

Huang YC; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan.
Weng CM; College of Medicine, Taipei Medical University, Taipei, Taiwan.
Lee MJ; College of Medicine, Taipei Medical University, Taipei, Taiwan.
Lin SM; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan.
Wang CH; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan.
Kuo HP; College of Medicine, Taipei Medical University, Taipei, Taiwan.

Clin Exp Allergy ; 49(1): 44-53, 2019 01.

Article em En | MEDLINE | ID: mdl-30107059

Assuntos

Antiasmáticos/administração & dosagem; Asma; Citocinas/imunologia; Omalizumab/administração & dosagem; Asma/tratamento farmacológico; Asma/imunologia; Asma/patologia; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Estudos Prospectivos; Índice de Gravidade de Doença

Palavras-chave

IL-25; IL-33; IgE; anti-IgE; severe asthma; thymic stromal lymphopoietin; type 2 cytokines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Citocinas / Antiasmáticos / Omalizumab Tipo de estudo: Observational_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google